We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$256B
AUM Growth
+$54.4B
Cap. Flow
+$36.7B
Cap. Flow %
14.37%
Top 10 Hldgs %
36.58%
Holding
10,953
New
1,924
Increased
4,219
Reduced
3,459
Closed
1,267

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.5%
2 Technology 2.1%
3 Healthcare 1.18%
4 Financials 0.9%
5 Industrials 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CREX icon
9226
Creative Realities
CREX
$38.1M
$103K ﹤0.01%
+15,824
New +$80.6K
JOFFU
9227
DELISTED
JOFF Fintech Acquisition Corp. Unit
JOFFU
$103K ﹤0.01%
10,266
-400,510
-98% -$4.01M
ORGN
9228
PUT
DELISTED
Origin Materials
ORGN
$102K ﹤0.01%
+413
New +$123K
PGEN icon
9229
PUT
Precigen
PGEN
$2.47B
$102K ﹤0.01%
15,600
-6,500
-29% -$45.4K
RNAC icon
9230
Cartesian Therapeutics
RNAC
$265M
$102K ﹤0.01%
+814
New +$96.9K
USX
9231
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$102K ﹤0.01%
+11,808
New +$126K
SREV
9232
DELISTED
ServiceSource International, Inc.
SREV
$102K ﹤0.01%
+72,033
New +$94.8K
CSPR
9233
PUT
DELISTED
Casper Sleep Inc.
CSPR
$102K ﹤0.01%
+12,400
New +$108K
STGW icon
9234
Stagwell
STGW
$2.23B
$101K ﹤0.01%
+17,236
New +$80.5K
WVE icon
9235
PUT
Wave Life Sciences
WVE
$1.19B
$101K ﹤0.01%
15,100
-88,300
-85% -$577K
PSTX
9236
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$101K ﹤0.01%
+10,110
New +$90.5K
AUVI
9237
DELISTED
Applied UV, Inc. Common Stock
AUVI
$101K ﹤0.01%
+82
New +$94.9K
PIAI.WS
9238
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$101K ﹤0.01%
100,590
-1,446
-1% -$1.26K
GOAC.WS
9239
DELISTED
GO Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock
GOAC.WS
$101K ﹤0.01%
91,607
-911
-1% -$901
SIC
9240
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$101K ﹤0.01%
+10,711
New +$101K
YELL
9241
DELISTED
Yellow Corporation Common Stock
YELL
$101K ﹤0.01%
15,448
-63,274
-80% -$471K
CCLD icon
9242
CareCloud
CCLD
$98.6M
$100K ﹤0.01%
+11,906
New +$98.9K
NGL icon
9243
CALL
NGL Energy Partners
NGL
$2.17B
$100K ﹤0.01%
+42,100
New +$94.3K
SLDB icon
9244
PUT
Solid Biosciences
SLDB
$857M
$100K ﹤0.01%
1,820
-2,480
-58% -$164K
SPRU icon
9245
Spruce Power Holding Corp
SPRU
$42.2M
$100K ﹤0.01%
1,495
-15,178
-91% -$894K
SVM
9246
PUT
Silvercorp Metals
SVM
$2.39B
$100K ﹤0.01%
+18,200
New +$106K
UBX
9247
DELISTED
Unity Biotechnology
UBX
$100K ﹤0.01%
+2,166
New +$104K
DTEA
9248
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$100K ﹤0.01%
+22,889
New +$88.5K
ADN
9249
DELISTED
Advent Technologies
ADN
$99K ﹤0.01%
341
-3,824
-92% -$1.27M
DHY
9250
Credit Suisse High Yield Credit Fund
DHY
$238M
$99K ﹤0.01%
+39,480
New +$97.6K

Similar funds

Jane Street's Q2 2021 Portfolio in Review

As of Q2 2021, Jane Street held 10,953 positions worth $256B, up 27% from $201B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $36.7B of net new capital in Q2 2021, opening 1,924 new positions and adding to 4,219 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.5% of assets, down from 2.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Baidu, an estimated $964M trimmed.

  • Jane Street's largest Q2 2021 buy was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.
  • Jane Street added most to iShares MBS ETF in Q2 2021, an estimated $629M increase.
  • Jane Street's biggest Q2 2021 reduction was Baidu, cutting an estimated $964M.
  • Jane Street fully exited Invesco Senior Loan ETF in Q2 2021, selling an estimated $369M.
  • Jane Street's ten largest holdings make up 37% of its $256B portfolio in Q2 2021.
  • Jane Street opened 1,924 new positions and closed 1,267 in Q2 2021.
  • Jane Street's portfolio value rose 27% quarter-over-quarter to $256B.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.